We will release Member Company Webinars on the Industry Relations Hub website the week prior to the conference. We are hopeful that all attendees will watch the Member Company Webinars before arriving on-site at the conference, as they serve as a primer for many of the business interactions that take place while attending the event.

Monday, February 27
7:00 am - 7:00 pm

Registration Open

Grande Registration Desk

7:00 am - 6:30 pm

Private Meeting Rooms Open

8:00 am - 9:15 am

Diversity, Inclusion, and Women’s Leadership Networking Breakfast and Session: Diversity of Thought

Palazzo Ballroom


Initiative Co-chairs: 

Harold Carter, Senior Vice President, Pharma Trade Relations, Express Scripts 

Jane Thompson, Head of US Account Management, UCB 

Guest Speaker:  

Latesha Byrd, CEO, Talent Development Advisor, PERFEQTA 


Tonya Adams, Head of Diversity and Inclusion, UCB 

Lei Ding, Senior Vice President, Market Access & Commercial Capabilities, Astellas  

Lilian Ndehi-Rice Associate Vice President, Pharmacy, Clinical, and Specialty Strategies, Humana, Inc.  

8:00 am - 9:15 am

Networking Breakfast

Mediterranean Porte-Cochere 

9:30 am - 12:00 pm


Mediterranean Ballroom


9:30 a.m. – 10:00 a.m.  

PCMA Leadership Welcome 

JC Scott, President & Chief Executive Officer, PCMA 

Adam Kautzner, President, Express Scripts, and PCMA Chairman of the Board

10:00 a.m. – 10:45 a.m.
Policy Changes and Implementation of IRA’s Drug Pricing Provisions 

Alex Hindman, Vice President, Industry Relations, OptumRx 

Chris Stewart, Vice President, Manufacturer Trade Relations and Operations, Humana 

Moderator: Ian Spatz, National Advisor, Manatt, Phelps & Phillips 


10:45 a.m. – 11:30 a.m.  

Hot Topics and Trends Impacting Today’s PBM and Pharma Business Strategies 

Steve Albers, Senior Vice President, Market Access & Public Affairs, Novo Nordisk 

Harold Carter, Senior Vice President, Pharma Trade Relations, Express Scripts

Rick Dudek, Senior Vice President, US Payer & Channel Access, Pfizer  

Bethanie Stein, Senior Vice President, Pharmacy Benefit Manager Services, Humana 

Moderator: Ian Spatz, National Advisor, Manatt, Phelps & Phillips 


11:30 a.m. – 12:00 p.m.  

Advanced Analytics to Identify Gaps in Care –

Daniel Knecht, Vice President & Chief Clinical Innovation Officer, CVS Caremark  

Using advanced analytics to identify individualized interventions not only reduces unnecessary spending but can also improve outcomes throughout a patient’s unique condition journey. Technology can help patients and their care teams gauge the efficacy of their care and how they’re managing their health overall. Utilizing a comprehensive patient view and a proactive monitoring approach, we can recommend targeted clinical interventions to patients that may otherwise be experiencing challenges with treatment.  By capturing metrics specific to a patient’s symptoms and functional status, we can not only optimize their individual treatment plan, but we can also apply machine learning to gather insights that could apply to – and improve care for – a much larger patient population with the same condition. 

By attending this session, you should be able to: 

  • Understand the increasingly effective ways PBMs work to identify patients in need of pharmaceutical treatment intervention   
  • Describe the ways PBMs utilize big data to improve outcomes and reduce unnecessary spend 
  • Explain how drugmakers are impacted and how they rely on PBMs to identify patients in need 
12:15 pm - 1:30 pm

Networking Lunch &

Member Company Lunch Receptions

Only pharmaceutical manufacturing companies will be permitted into the Member Company lunches


Ascent Health: DaVinci Lawn A

Express Scripts: Valencia Lawn A

Humana: Valencia Lawn B

Prime/Magellan: DaVinci Lawn B

1:30 pm - 3:00 pm


Palazzo Ballroom


1:30 p.m. – 2:00 p.m. 

The Rise of Alternative Funding Programs and Challenges Ahead
Mike Einodshofer, Chief Pharmacy Officer, OptumRx

Alternative funding programs are a recent concept in the self-insured market where high cost drugs are “carved out” of the employer’s coverage to its members, thereby making the member “uninsured” and in theory eligible for needs based patient assistance program coverage.  This practice is not short on pitfalls for patients, payers and many others in the business of pharmaceutical care.   

By attending this session, you should be able to:

  • Explain how member disruption and decreased clinical care negatively impacts the patient’s chances for optimal health outcomes  
  • Understand how companies and industries in the drug supply and payment chain are impacted by this practice  
  • Describe what steps are being taken to educate and address the implications of this practice  


2:00 p.m. – 2:30 p.m.  

Using Social Determinant Data to Optimize Medication Adherence and Overall Health
Kodi Reel, Chief Business Development Officer, Forsyth Health – an Evernorth Company 

Medication adherence has been a long-standing challenge in healthcare. While it is easily identified as a root cause for many poor health outcomes, it’s not easily solved for. Social determinants of Health data offers a unique opportunity to tap into underlying factors that can be impacting the ability and motivation of patients to take their medications. Kodi will help highlight the rising demand for healthcare to become more creative and thoughtful in how it leverages data to help solve one of healthcare’s biggest challenges.

By attending this session you should be able to:

  • Understand why medication adherence is such a challenge 
  • Describe the barriers to medication nonadherence 
  • Explain the role that Social Determinants of Health Data plays in market share strategy 
  • Understand how Social Determinats of Health Data can make it actionable


2:30 p.m. – 3:00 p.m.
The US Pharmaceutical Market: Trends, Issues and Outlook

Doug Long, Vice President Industry Relations, IQVIA   

Doug Long is a regular and popular presenter at PCMA conferences, and for good reason.  His presentations always offer an insightful analysis of the most up-to-date industry data and highlight pharmacy trends, issues, and forecasts. His presentation this year reflects many compelling and unique trends being seen in the post-pandemic healthcare environment.

By attending this session, you should be able to:

  • Understand where the US Pharmaceutical market growth has been and near-term forecast for growth.
  • Describe the performance of the various sectors of the dispensing side.
  • Explain the performance of Brand, Generic and Specialty products.
  • Identify which factors will affect future growth.
6:00 pm - 8:00 pm

Cocktail and Dinner Reception with Live Music

Valencia Lawn

Tuesday, February 28
7:00 am – 4:00 pm

Registration Open

Grande Registration Desk

7:00 am - 5:30 pm

Private Meeting Rooms Open

8:00 am - 9:15 am

Emerging Biopharmaceutical Company Networking Breakfast and Session: Unlocking the Value of Small and Emerging Pharmaceutical Manufacturer Relationships with PBM’s

Palazzo Ballroom


Ed Adamcik, President, Ascent Health Services  

Jim Clement, Partner, Coeus Consulting Group 

Justin Lester, Vice President, General Manager, Emisar 

Moderator: Tom Knox, President, Fathom Healthcare Solutions  

8:00 am - 9:15 am

Networking Breakfast

Mediterranean Porte-Cochere

9:15 am - 12:15 pm


Mediterranean Ballroom 


9:30 a.m. – 10:00 a.m.  

Reducing Cost-Sharing in Part D: PBM Perspectives in Managing Care 

Tim Dube, Vice President for Regulatory Affairs, PCMA  

Amanda Karp, Assistant General Counsel, Elixir Rx Solutions  

Moderator: Ian Spatz, National Advisor, Manatt, Phelps & Phillips 


10:00 a.m. – 10:45 a.m.  

PBM Perspectives on New and Future Biosimilars Market Introductions 

Josh Fredell, Vice President & Head of PBM & Specialty Product Innovation, CVS Health  

Jamey Millar, Senior Vice President Industry Relations, OptumRx  

Moderator: Ian Spatz, National Advisor, Manatt, Phelps & Phillips 


10:45 a.m. – 11:15 a.m.  

Clinical Support Programs to Achieve Clinical Efficacy: GLP1 drug class case study 

Jackie Todisco, Executive Director, Care Management, CVS Health, CVS Health  

The GLP1 drug class is one of the most discussed today, both within the pharmaceutical care, payment and delivery industry, and more broadly in the general public.  These drugs represent a highly effective new therapy in the treatment of obesity.  Many complexities exist in this new drug class. Ms. Todisco will unpack these complexities and discuss how PBMs are working to manage care and optimize clinical outcomes.

By attending this session, you should be able to:

  • Understand the GLP1 class of drugs, and the disease state and comorbidities these drugs treat
  • Explain how certain medications gain FDA approval with companion patient support programs
  • Describe how a PBM medication support program serves the interests of patients, payers and drug makers
  • Understand how PBMs devise product and patient support programs to optimize clinical efficacy


11:15 a.m. – 11:45 a.m. 

Beyond the PBM’s Core Functionality – Driving Market Access with Innovation

Oron Stenesh, Vice President Product, Optum Rx 

PBMs are driving market access with innovation supporting pharmaceutical manufacturers, plan sponsors, plan members and consumers. In this session, you’ll hear how OptumRx thinks about the product development that enables that access. With product focus areas ranging from consumer affordability and price transparency to managing specialty drug costs, OptumRx is bringing market-leading solutions to the fore, answering today’s demands and preparing for tomorrow’s evolving marketplace needs.   

By attending this session, you should be able to:

  • Describe the role of PBMs and the services they manage to support payer clients and pharmaceutical manufacturers across the supply chain. 
  • Explain how PBMs enable and support access to pharmaceuticals through innovation, product development and technology that drives interoperability in the supply and payment chain.
  • Understand key product and technology focus areas underpinning the PBM’s work.


11:45 a.m. – 12:15 p.m.  

Pharma 101 and Future Trends and Impacts
Harry Travis, President, The Travis Group  

Are you new or relatively new to the US pharmaceutical and pharmacy market? Have you reached the point of acronym overload? Or perhaps you know your corner of the pharma world but would like to see the entire market picture. Mr. Travis will provide a fast-paced overview of the major players and processes that drive the $500 billion US pharmaceutical market. His presentation will span the discovery of the atorvastatin molecule to the latest advances in gene therapy.

By attending this session, you should be able to

  • Know how a molecule becomes an approved drug. 
  • Know how a drug enters the US market.
  • Know who the key players are in the market.
  • Know what are the major trends in the market.
  • Know what the future holds.
12:30 pm – 1:45 pm

Networking Lunch &

Member Company Lunch Receptions

Only pharmaceutical manufacturing companies will be permitted into the Member Company lunches


CVS Health: Valencia Lawn A

MedImpact: DaVinci Lawn B

OptumRx: DaVinci Lawn A

PerformRx: Valencia Lawn B

Zinc Health Services: DaVinci Lawn North


8:00 pm - 10:00 pm

Cocktail and Dessert Reception

JW Lobby Lounge – Evr Bar

Join your peers for dessert, cocktails, and conversation with colleagues at this after-dinner reception.